Clinical Trial Update: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [Phase 2]

View source ↗

Summary

This Phase 2 trial of talampanel in recurrent high-grade gliomas was terminated. No results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma Multiforme

Drugs mentioned

• Talampanel (talampanel)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 2 | Status: TERMINATED